Jade Biosciences (JBIO) EPS (Weighted Average and Diluted) (2021 - 2026)
Jade Biosciences posted quarterly EPS (Weighted Average and Diluted) of -$0.57 for Q1 2026, up 95.29% year-on-year from -$0.29 in Q1 2025, and down 418.18% on a QoQ basis from -$0.11 in Q4 2025.
Jade Biosciences (JBIO) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.57 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 95.29% year-over-year to -$0.57; the trailing twelve-month figure through Mar 2026 stood at -$2.02 (up 93.75% YoY), and the FY2025 full-year result was -$3.19, down 30.74% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.57, down from -$0.11 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.11 in Q4 2025 and bottomed at -$14.89 in Q4 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.67 (2023), against an average of -$2.36.
- The widest annual swing landed in 2024, when EPS (Weighted Average and Diluted) plunged 1912.16%; it then surged 99.26% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.61 in 2022, then dropped by 21.31% to -$0.74 in 2023, then slumped by 1912.16% to -$14.89 in 2024, then soared by 99.26% to -$0.11 in 2025, then sank by 418.18% to -$0.57 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.57 (Q1 2026), -$0.11 (Q4 2025), and -$0.48 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.48 |
| Jun 30, 2025 | -0.86 |
| Mar 31, 2025 | -12.10 |
| Dec 31, 2024 | -14.89 |
| Sep 30, 2024 | -5.16 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.83 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -0.71 |
| Jun 30, 2023 | -0.76 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.45 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | -0.26 |